Armata Pharmaceuticals (ARMP) Interest & Investment Income (2018 - 2024)
Quarterly results put Interest & Investment Income at $221000.0 for Q2 2024, up 380.43% from a year ago — trailing twelve months through Jun 2024 was $388000.0 (up 345.98% YoY), and the annual figure for FY2023 was $179000.0, up 517.24%.
Armata Pharmaceuticals has reported Interest & Investment Income over the past 7 years, most recently at $221000.0 for Q2 2024.
- Interest & Investment Income reached $221000.0 in Q2 2024 per ARMP's latest filing, up from $52000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $221000.0 in Q2 2024 and bottomed at $1000.0 in Q4 2021.
- Median Interest & Investment Income over the past 5 years was $11500.0 (2022), compared with a mean of $32125.0.
- The largest annual shift saw Interest & Investment Income tumbled 95.83% in 2020 before it soared 1700.0% in 2023.
- Over 5 years, Interest & Investment Income stood at $4000.0 in 2020, then tumbled by 75.0% to $1000.0 in 2021, then soared by 1300.0% to $14000.0 in 2022, then soared by 385.71% to $68000.0 in 2023, then surged by 225.0% to $221000.0 in 2024.
- Business Quant data shows Interest & Investment Income for ARMP at $221000.0 in Q2 2024, $52000.0 in Q1 2024, and $68000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 221,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 9,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 13,000.00 |
| Jun 30, 2019 | 28,000.00 |
| Mar 31, 2019 | 48,000.00 |
| Dec 31, 2018 | 65,000.00 |
| Sep 30, 2018 | 70,000.00 |
| Jun 30, 2018 | 58,000.00 |